Abstract
P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have